Cargando…
Charge variants characterization and release assay development for co-formulated antibodies as a combination therapy
Combination therapy is a fast-growing strategy to maximize therapeutic benefits to patients. Co-formulation of two or more therapeutic proteins has advantages over the administration of multiple medications, including reduced medication errors and convenience for patients. Characterization of co-for...
Autores principales: | Cao, Mingyan, De Mel, Niluka, Shannon, Anthony, Prophet, Meagan, Wang, Chunlei, Xu, Weichen, Niu, Ben, Kim, Jun, Albarghouthi, Methal, Liu, Dengfeng, Meinke, Eric, Lin, Shihua, Wang, Xiangyang, Wang, Jihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512943/ https://www.ncbi.nlm.nih.gov/pubmed/30786796 http://dx.doi.org/10.1080/19420862.2019.1578137 |
Ejemplares similares
-
Analytical characterization of coformulated antibodies as combination therapy
por: Kim, Jun, et al.
Publicado: (2020) -
Rapid monitoring of high‐mannose glycans during cell culture process of therapeutic monoclonal antibodies using lectin affinity chromatography
por: Kim, Jun, et al.
Publicado: (2022) -
Characterization and analysis of scFv-IgG bispecific antibody size variants
por: Cao, Mingyan, et al.
Publicado: (2018) -
Nonspecific cleavages arising from reconstitution of trypsin under mildly acidic conditions
por: Niu, Ben, et al.
Publicado: (2020) -
A systematic approach for analysis and characterization of mispairing in bispecific antibodies with asymmetric architecture
por: Wang, Chunlei, et al.
Publicado: (2018)